Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David El-Qutob

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Vaccines|April 30, 2015
Vaccine development and new attempts of treatment for ragweed allergyDavid El-Qutob
Clinical Reviews in Allergy & Immunology|June 7, 2015
Off-Label Uses of OmalizumabDavid El-Qutob
Recent Patents on Inflammation & Allergy Drug Discovery|October 26, 2011
New methods of prevention and treatment of allergic diseasesDavid El-Qutob López
Recent Patents on Inflammation & Allergy Drug Discovery|June 6, 2016
Recent Patents for the Treatment of AsthmaDavid El-Qutob, Isabela Raducan
Recent Patents on Inflammation & Allergy Drug Discovery|November 19, 2013
Recent advances in immunotherapy for allergic diseasesDavid El-Qutob, Gemma Mencia, Enrique Fernandez-Caldas
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Allergen immunotherapy, cancer, and immune disordersDavid El-Qutob, Victor Matheu, Enrique Fernandez-Caldas
Immunotherapy|May 19, 2016
Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapyDavid El-Qutob, Francisco Moreno, Alicia Subtil-Rodríguez
Recent Patents on Inflammation & Allergy Drug Discovery|February 12, 2015
New developments in oral vaccines and mucosal adjuvantsJose L Subiza, David El-Qutob, Enrique Fernandez-Caldas
The World Allergy Organization Journal|November 17, 2021
Cancer: Still a contraindication for allergen immunotherapy?: Specific immunotherapy and cancerDavid El-Qutob, Antonio Letrán, Victor Matheu, et al.
Frontiers in Allergy|April 7, 2022
Precision Medicine in Mite Allergic RhinitisRuperto González-Pérez, David El-Qutob, Antonio Letrán, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Vaccines|April 30, 2015
Vaccine development and new attempts of treatment for ragweed allergyDavid El-Qutob
Clinical Reviews in Allergy & Immunology|June 7, 2015
Off-Label Uses of OmalizumabDavid El-Qutob
Recent Patents on Inflammation & Allergy Drug Discovery|October 26, 2011
New methods of prevention and treatment of allergic diseasesDavid El-Qutob López
Recent Patents on Inflammation & Allergy Drug Discovery|June 6, 2016
Recent Patents for the Treatment of AsthmaDavid El-Qutob, Isabela Raducan
Recent Patents on Inflammation & Allergy Drug Discovery|November 19, 2013
Recent advances in immunotherapy for allergic diseasesDavid El-Qutob, Gemma Mencia, Enrique Fernandez-Caldas
Current Opinion in Allergy and Clinical Immunology|September 27, 2022
Allergen immunotherapy, cancer, and immune disordersDavid El-Qutob, Victor Matheu, Enrique Fernandez-Caldas
Immunotherapy|May 19, 2016
Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapyDavid El-Qutob, Francisco Moreno, Alicia Subtil-Rodríguez
Recent Patents on Inflammation & Allergy Drug Discovery|February 12, 2015
New developments in oral vaccines and mucosal adjuvantsJose L Subiza, David El-Qutob, Enrique Fernandez-Caldas
The World Allergy Organization Journal|November 17, 2021
Cancer: Still a contraindication for allergen immunotherapy?: Specific immunotherapy and cancerDavid El-Qutob, Antonio Letrán, Victor Matheu, et al.
Frontiers in Allergy|April 7, 2022
Precision Medicine in Mite Allergic RhinitisRuperto González-Pérez, David El-Qutob, Antonio Letrán, et al.
Pageof 2